2012 AAPS National Biotechnology Conference

May 21–23, 2012
Sheraton San Diego Hotel and Marina, San Diego 

Program Committee

Steven W. Martin, Ph.D., chair 
Pfizer Inc.

Phillip Ramsey, chair-elect 
SAIC-Frederick

Raimund M. Peter, 2013 chair
AstraZeneca 

Binodh S. DeSilva, Ph.D., past chair 
Bristol-Myers Squibb

Paul W. Rhyne, Ph.D.
Bristol-Myers Squibb., APQ section

Kamal L. Egodage, Ph.D.
Novartis Biologics, BIOTEC section

Madhu Cherukury, Ph.D.
Allergan, CPTR section

Eric C. Peterson, Ph.D.
University of Arkansas Medical Sciences, DDDI section

Parag Kolhe, Ph.D.
Pfizer Inc., FDD section

Amol A. Mungikar 
Millennium, The Takeda Oncology Company, MSE section

Giovanni Pauletti, Ph.D.
University of Cincinnati, PPB section

Raimund M. Peter, Ph.D.
AstraZeneca, PPDM section and 2013 chair-elect

Deepa S. Deshpande, Ph.D., RAC
Universal Regulatory Inc., RS section

James Polli, Ph.D.
University of Maryland, AAPS Executive Council liaison 

Karoline B. Bechtold-Peters, Ph.D.
F. Hoffman-La Roche AG, EAPB member  

Keith Webber, Ph.D.
U.S. Food and Drug Administration, FDA representative